Trial Profile
Immunogenicity and safety of pneumoccocal 13-valent vaccine conjugate in pediatric patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 23 Mar 2016 New trial record